Biochemistry

Meet Katherine Clowes Moster, a trainee in the lab of Chuck Sanders in the Department of Biochemistry. Read More

Kate is a graduate student in the Biochemistry Graduate Program and a member of the Sanders lab since 2020. Her research focuses on the potassium channel KCNQ1 and mutations that cause a cardiac disorder called type 1 long QT syndrome (LQT1). Sanders lab researchers have determined that mistrafficking is a common cause of KCNQ1 dysfunction in LQT1. Kate’s effort to search for small molecules that might remedy this mistrafficking provides an early foundation for possible drug discovery efforts to treat LQT1 and related cardiac disorders. Read More

Tune in to Professor of Biochemistry Chuck Sanders' yearly Halloween interview, this year featuring Maud Menten, co-creator of the Michaelis-Menten enzyme kinetics equation. Read More

Vanderbilt researchers probe the mysteries of an enzyme that could be used as a tool in basic research and medicinal chemistry. Read More

Vanderbilt-Ingram names William Tansey associate director for Shared Resources and Douglas Kojetin as co-leader of the Genome Maintenance Research Program. The Genome Maintenance Research Program is focused on understanding how DNA is damaged, repaired, packaged, expressed and replicated. Read More

David Cortez and Rahul Bhowmick won the Chancellor’s Award for Research for their work, “RAD51 Bypasses the CMG Helicase to Promote Replication Fork Reversal,” which was published in the journal Science. Read More

Kojetin lab members Christopher Williams, staff scientist Paola Munoz-Tello and a collaborator from the Scripps Institute use NMR spectroscopy to investigate Pin1- PPARγ binding. Read More

Juan Carvajal-García has been named a 2025 Destination Biochemistry Advanced Postdoctoral Scholar, a distinction granted by the Department of Biochemistry at the School of Medicine Basic Sciences. The award will support his transition into an independent research position. Read More

Vanderbilt biochemists find role for lipids in age-related vision loss—and pave the way for potential new therapies. Read More

Scott Hiebert, Hortense B. Ingram Chair in Cancer Research, has been named Chief Scientific Officer of the  Cancer Prevention and Research Institute of Texas. Hiebert served as chair of the National Cancer Advisory Board and brought global recognition to the Vanderbilt-Ingram Cancer Center during his 28 years at Vanderbilt. Read More